Cargando…

Anti‐inflammatory effects of infliximab in mice are independent of tumour necrosis factor α neutralization

Infliximab (IFX) has been used repeatedly in mouse preclinical models with associated claims that anti‐inflammatory effects are due to inhibition of mouse tumour necrosis factor (TNF)‐α. However, the mechanism of action in mice remains unclear. In this study, the binding specificity of IFX for mouse...

Descripción completa

Detalles Bibliográficos
Autores principales:	Assas, B. M., Levison, S. E., Little, M., England, H., Battrick, L., Bagnall, J., McLaughlin, J. T., Paszek, P., Else, K. J., Pennock, J. L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2016
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5217947/ https://www.ncbi.nlm.nih.gov/pubmed/27669117 http://dx.doi.org/10.1111/cei.12872

Ejemplares similares

Early induction of C/EBPβ expression as a potential marker of steroid responsive colitis
por: Assas, Mushref Bakri, et al.
Publicado: (2019)

Author Correction: Early induction of C/EBPβ expression as a potential marker of steroid responsive colitis
por: Assas, Mushref Bakri, et al.
Publicado: (2021)

Anti‐tumour necrosis factor‐α‐induced lupus in a patient receiving infliximab for sarcoidosis
por: Stranks, Lachlan, et al.
Publicado: (2022)

The clinical response to infliximab in rheumatoid arthritis is in part dependent on pretreatment tumour necrosis factor α expression in the synovium
por: Wijbrandts, C A, et al.
Publicado: (2008)

Circulating tumour necrosis factor-α bioactivity in rheumatoid arthritis patients treated with infliximab: link to clinical response
por: Marotte, Hubert, et al.
Publicado: (2005)

Tumour necrosis factor-α in nasal allergy
por: Hisamatsu, K., et al.
Publicado: (1995)

In vivo isolated kidney perfusion with tumour necrosis factor α (TNF-α) in tumour-bearing rats
por: Veen, A H van der, et al.
Publicado: (1999)

Quantitative comparison of the neutralizing capacity, immunogenicity and cross-reactivity of anti-TNF-α biologicals and an Infliximab-biosimilar
por: Buurman, D. J., et al.
Publicado: (2018)

Tumor necrosis factor-mediated disposition of infliximab in ulcerative colitis patients
por: Berends, Sophie E., et al.
Publicado: (2019)

Calcitonin gene-related peptide is a key neurotransmitter in the neuro-immune axis
por: Assas, Bakri M., et al.
Publicado: (2014)

The anticancer drug mithramycin A sensitises tumour cells to apoptosis induced by tumour necrosis factor (TNF)
por: Duverger, V, et al.
Publicado: (2004)

Commercially Available Antibodies to Human Tumour Necrosis Factor-α Tested for Cross-Reactivity with Ovine and Bovine Tumour Necrosis Factor-α using Flow Cytometric Assays
por: Dernfalk, J, et al.
Publicado: (2004)

Remission of intestinal Behçet's disease treated with anti-tumor necrosis factor α monoclonal antibody (Infliximab)
por: Lee, Jung Hoon, et al.
Publicado: (2007)

Antitumor Necrosis Factor-Alpha (TNF-α) Infliximab-Induced Pleural Effusion and Pericarditis in Crohn's Disease
por: Fonseca, Ashley, et al.
Publicado: (2021)

The effect of tumour necrosis factor-α (TNF-α) muteins on human neutrophils in vitro
por: Tchorzewski, H., et al.
Publicado: (1993)

Trichuris muris infection drives cell-intrinsic IL4R alpha independent colonic RELMα+ macrophages
por: Forman, Ruth, et al.
Publicado: (2021)

Baseline tumour necrosis factor alpha levels predict the necessity for dose escalation of infliximab therapy in patients with rheumatoid arthritis
por: Takeuchi, Tsutomu, et al.
Publicado: (2011)

Tumour necrosis factor‐α inhibition can stabilize disease in progressive vitiligo
por: Webb, K.C., et al.
Publicado: (2015)

Tumour necrosis factor α stimulates resorption and inhibits synthesis of proteoglycan in cartilage
por: Saklatvala, J.
Publicado: (1986)

Melanoma cell migration is upregulated by tumour necrosis factor-α and suppressed by α-melanocyte-stimulating hormone
por: Zhu, N, et al.
Publicado: (2004)

Tumor necrosis factor-α antibodies (infliximab, adalimumab and certolizumab) in Crohn's disease: systematic review and meta-analysis
por: Kawalec, Paweł, et al.
Publicado: (2013)

Genetic analysis of the Trichuris muris-induced model of colitis reveals QTL overlap and a novel gene cluster for establishing colonic inflammation
por: Levison, Scott E, et al.
Publicado: (2013)

Tumour necrosis factor-α and adenosine in endotoxin shockleading related cardiovascular symptoms
por: Sipka, S., et al.
Publicado: (1995)

Rheumatoid Arthritis: Refractory to Infliximab, a Tumor Necrosis Factor Inhibitor
por: Solehan, Hana Maizuliana bt, et al.
Publicado: (2011)

Inhibitory effect of esculentoside A on tumour necrosis factor α production by human monocytes
por: Wang, H-B., et al.
Publicado: (1996)

Circulating Cytokines and Cytokine Receptors in Infliximab Treatment Failure Due to TNF-α Independent Crohn Disease
por: Steenholdt, Casper, et al.
Publicado: (2016)

Effects of tumour necrosis factor-α on BrdU incorporation in cultured human enterocytes
por: McDevitt, J., et al.
Publicado: (1995)

A Study of Single Nucleotide Polymorphisms of Tumour Necrosis Factor α-1031 And Tumour Necrosis Factor β+ 252 in Chronic Rhinosinusitis
por: Misron, Khairunnisak, et al.
Publicado: (2017)

Overnight variations in cortisol, interleukin 6, tumour necrosis factor α and other cytokines in people with rheumatoid arthritis
por: Perry, M G, et al.
Publicado: (2009)

Clinical response to the anti-tumor necrosis factor alpha antibody infliximab in patients with ankylosing spondylitis over 3 years
por: Baraliakos, X, et al.
Publicado: (2005)

Radiographic progression in patients with ankylosing spondylitis after 2 years of treatment with the tumor necrosis factor alpha antibody infliximab
por: Baraliakos, X, et al.
Publicado: (2005)

Effects of tumour necrosis factor α upon the metabolism of the endocannabinoid anandamide in prostate cancer cells
por: Karlsson, Jessica, et al.
Publicado: (2017)

Paradoxical effects of tumour necrosis factor-α in adjuvant-induced arthritis
por: Williams, Richard O
Publicado: (2008)

Exogenous tumour necrosis factor α induces suppression of autoimmune arthritis
por: Kim, Eugene Y, et al.
Publicado: (2008)

Gene-Specific Linear Trends Constrain Transcriptional Variability of the Toll-like Receptor Signaling
por: Bagnall, James, et al.
Publicado: (2020)

Caffeine potentiates the lethality of tumour necrosis factor in cancer cells.
por: Belizario, J. E., et al.
Publicado: (1993)

Enhanced anti-tumour activity of carmustine (BCNU) with tumour necrosis factor in vitro and in vivo.
por: Jones, A. L., et al.
Publicado: (1990)

Postchemoembolisation syndrome – tumour necrosis or hepatocyte injury?
por: Wigmore, S J, et al.
Publicado: (2003)

Tumour Necrosis Factor-α Inhibition Improves Stroke Outcome in a Mouse Model of Rheumatoid Arthritis
por: Bonetti, N. R., et al.
Publicado: (2019)

Activated macrophages promote Wnt signalling through tumour necrosis factor-α in gastric tumour cells
por: Oguma, Keisuke, et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_qn62fbpve6jepn2529gmj95akg